Teladoc Health, Inc. Common Stock (TDOC)
8.5650
+1.6850 (24.49%)
NYSE · Last Trade: Oct 29th, 11:15 AM EDT
Detailed Quote
| Previous Close | 6.880 |
|---|---|
| Open | 7.920 |
| Bid | 8.560 |
| Ask | 8.570 |
| Day's Range | 7.900 - 8.990 |
| 52 Week Range | 4.400 - 9.887 |
| Volume | 8,078,984 |
| Market Cap | 1.40B |
| PE Ratio (TTM) | -9.016 |
| EPS (TTM) | -1.0 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 3,865,217 |
Chart
About Teladoc Health, Inc. Common Stock (TDOC)
Teladoc Health is a leading telehealth company that provides virtual healthcare services, connecting patients with a wide range of healthcare professionals through digital platforms. The company offers various services, including remote consultations, mental health support, chronic condition management, and preventive care. By leveraging technology, Teladoc facilitates access to healthcare for individuals regardless of their location, aiming to improve health outcomes and enhance the patient experience. Their comprehensive solutions cater to both individual consumers and large employers, helping to make healthcare more accessible and efficient. Read More
News & Press Releases
Should investors follow Wood's lead with this eVTOL manufacturer?
Via The Motley Fool · October 29, 2026
Teladoc Health (NYSE:TDOC) reported third-quarter 2026 revenue near the upper end of its guidance range and adjusted EBITDA above expectations, as growth in Integrated Care and BetterHelp insurance revenue partly offset continued pressure in BetterHelp’s cash-pay business.
Consolidated revenue tota
Via MarketBeat · October 29, 2026
A unified care platform and insurance-focused strategy position Teladoc to stabilize revenue while managing $1 billion in convertible debt due next June.
Via The Motley Fool · October 29, 2026
Insurance mental health revenue surged amid cash-pay headwinds.
Via The Motley Fool · October 29, 2026
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q3 2026 results exceeding the market’s revenue expectations, but revenue fell by 3.4% y...
Via StockStory · October 28, 2026
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2025 (“Third Quarter 2025”).
By Teladoc Health, Inc. · Via GlobeNewswire · October 28, 2026
Digital medical services platform Teladoc Health (NYSE:TDOC) will be reporting results this Wednesday afternoon. Here’s what investors should know. Teladoc m...
Via StockStory · October 26, 2026
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
By Teladoc Health, Inc. · Via GlobeNewswire · October 14, 2026
What Happened? A number of stocks fell in the afternoon session after the major indices pulled back and tech-oriented equities fell as the Bureau of Labor St...
Via StockStory · October 14, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...
Via StockStory · October 12, 2026
New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows
By Teladoc Health, Inc. · Via GlobeNewswire · October 7, 2026
Consumer spending on healthcare is relatively more stable compared to most other industries.
Via The Motley Fool · September 29, 2026
What Happened? A number of stocks fell in the afternoon session after the benchmark U.S. 10-year Treasury yield climbed back above 5% to levels not seen sinc...
Via StockStory · September 28, 2026
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
By Teladoc Health, Inc. · Via GlobeNewswire · September 25, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via StockStory · September 24, 2026
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi...
Via StockStory · September 17, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via StockStory · September 15, 2026
Don't catch a falling knife.
Via The Motley Fool · September 8, 2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.
By Teladoc Health, Inc. · Via GlobeNewswire · September 3, 2026
Over the past six months, Teladoc has been a great trade, beating the S&P 500 by 11.4%. Its stock price has climbed to $6.36, representing a healthy 23.2% in...
Via StockStory · September 2, 2026
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth
By Teladoc Health, Inc. · Via GlobeNewswire · August 31, 2026
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 25, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · August 25, 2026
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via StockStory · August 24, 2026
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 18, 2026
